Publications
15- Bilodeau L, Boulay ME, Prince P, Boisvert P, Boulet LP. Comparative clinical and airway inflammatory features of asthmatics with or without polyps.. Rhinology 2010; 48(4):420-5.
- Coman I, Bilodeau L, Lavoie A, Carricart M, Tremblay F, Zlosnik JE, Berthiaume Y. Ralstonia mannitolilytica in cystic fibrosis: A new predictor of worse outcomes.. Respir Med Case Rep 2016; 20(0):48-50.
- Nadeau M, Boulay MÈ, Milot J, Lepage J, Bilodeau L, Maltais F, Boulet LP. Comparative prevalence of co-morbidities in smoking and non-smoking asthma patients with incomplete reversibility of airway obstruction, non-smoking asthma patients with complete reversibility of airway obstruction and COPD patients.. Respir Med 2017; 125(0):82-88.
- Coman I, Bilodeau L, Lavoie A, Carricart M, Tremblay F, Zlosnik JE, Berthiaume Y. Ralstonia mannitolilytica in cystic fibrosis: A new predictor of worse outcomes.. Respir Med Case Rep 2017; 20(0):48-50.
- Boulet LP, Boulay MÈ, Dérival JL, Milot J, Lepage J, Bilodeau L, Maltais F.. Asthma-COPD Overlap Phenotypes and Smoking :Comparative features of asthma in smoking or non-smoking patients with an incomplete reversibility of airway obstruction.. COPD 2018; 15(2):130-138.
- Boulet LP, Boulay ME, Milot J, Lepage J, Bilodeau L, Maltais F.. Longitudinal comparison of outcomes in patients with smoking-related asthma-COPD overlap and in non-smoking asthmatics with incomplete reversibility of airway obstruction.. Int J Chron Obstruct Pulmon Dis 2019; 14(0):493-498.
- Mathieu D, Daoust VC, Campeau MP, Filion É, Bilodeau L, Bahig H, Roberge D, Lenglet A, Bedwani S. Central3D: A Computer Tool to Help Clinicians Differentiate Central and Peripheral Lung Tumors.. Pract Radiat Oncol 2019; 9(1):e98-e102.
- Lin YC, Keenan K, Gong J, Panjwani N, Avolio J, Lin F, Adam D, Barrett P, Bégin S, Berthiaume Y, Bilodeau L, Bjornson C, Brusky J, Burgess C, Chilvers M, Consunji-Araneta R, Côté-Maurais G, Dale A, Donnelly C, Fairservice L, Griffin K, Henderson N, Hillaby A, Hughes D, Iqbal S, Itterman J, Jackson M, Karlsen E, Kosteniuk L, Lazosky L, Leung W, Levesque V, Maille É, Mateos-Corral D, McMahon V, Merjaneh M, Morrison N, Parkins M, Pike J, Price A, Quon BS, Reisman J, Smith C, Smith MJ, Vadeboncoeur N, Veniott D, Viczko T, Wilcox P, van Wylick R, Cutting G, Tullis E, Ratjen F, Rommens JM, Sun L, Solomon M, Stephenson AL, Brochiero E, Blackman S, Corvol H, Strug LJ. Cystic fibrosis-related diabetes onset can be predicted using biomarkers measured at birth.. Genet Med 2021; 23(5):927-933.
- Lin YC, Keenan K, Gong J, Panjwani N, Avolio J, Lin F, Adam D, Barrett P, Bégin S, Berthiaume Y, Bilodeau L, Bjornson C, Brusky J, Burgess C, Chilvers M, Consunji-Araneta R, Côté-Maurais G, Dale A, Donnelly C, Fairservice L, Griffin K, Henderson N, Hillaby A, Hughes D, Iqbal S, Itterman J, Jackson M, Karlsen E, Kosteniuk L, Lazosky L, Leung W, Levesque V, Maille É, Mateos-Corral D, McMahon V, Merjaneh M, Morrison N, Parkins M, Pike J, Price A, Quon BS, Reisman J, Smith C, Smith MJ, Vadeboncoeur N, Veniott D, Viczko T, Wilcox P, van Wylick R, Cutting G, Tullis E, Ratjen F, Rommens JM, Sun L, Solomon M, Stephenson AL, Brochiero E, Blackman S, Corvol H, Strug LJ. Correction to: Cystic fibrosis-related diabetes onset can be predicted using biomarkers measured at birth.. Genet Med 2021; 23(11):2235-2236.
- Veit G, Velkov T, Xu H, Vadeboncoeur N, Bilodeau L, Matouk E, Lukacs GL. A Precision Medicine Approach to Optimize Modulator Therapy for Rare CFTR Folding Mutants.. J Pers Med 2021; 11(7):643.
- Flume PA, Fischer Biner R, Downey DG, Brown C, Jain M, Fischer R, De Boeck K, Sawicki GS, Chang P, Paz-Diaz H, Rubin JL, Yang Y, Hu X, Pasta DJ, Millar SJ, Campbell D, Wang X, Ahluwalia N, Owen CA, Wainwright CE; VX14-661-110 study group (Bilodeau L parmi les collaborateurs). Long-term safety and efficacy of tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study. Lancet Respir Med 2021; 9(7):733-746.
- Millaire É, Ouellet É, Fortin M, Martel S, Milot J, Bilodeau L, Conti M, Provencher S, Dion G. Outcomes Following Surgical Lung Biopsy for Interstitial Lung Diseases: A Monocenter Experience.. Thorac Cardiovasc Surg 2022; 70(7):583-588.
- Gong J, He G, Wang C, Bartlett C, Panjwani N, Mastromatteo S, Lin F, Keenan K, Avolio J, Halevy A, Shaw M, Esmaeili M, Côté-Maurais G, Adam D, Bégin S, Bjornson C, Chilvers M, Reisman J, Price A, Parkins M, van Wylick R, Berthiaume Y, Bilodeau L, Mateos-Corral D, Hughes D, Smith MJ, Morrison N, Brusky J, Tullis E, Stephenson AL, Quon BS, Wilcox P, Leung WM, Solomon M, Sun L, Brochiero E, Moraes TJ, Gonska T, Ratjen F, Rommens JM, Strug LJ. Genetic evidence supports the development of SLC26A9 targeting therapies for the treatment of lung disease.. NPJ Genom Med 2022; 7(1):28.
- Murru A, Vadeboncoeur N, Therrien AA, Coderre L, Vaillancourt M, Labrecque MM, Berthiaume Y, Damien A, Brochiero E, Lessage S, Flamand N, Bilodeau L, Fernandes M.. Association of low-density neutrophils with lung function and disease progression in adult cystic fibrosis.. J Cyst Fibros 2023; 22(6):1080-1084.
- Vézina FA, Bouchard PA, Breton-Gagnon É, Dion G, Viglino D, Roy P, Bilodeau L, Provencher S, Denault MH, Saey D, Lellouche F, Maltais F. Automated O(2) Titration Alone or With High-Flow Nasal Cannula During Walking Exercise in Chronic Lung Diseases.. Respir Care 2023; 0(0):respcare.10810.
